环胺与葡萄糖皮质类药物联合治疗对异常性膜性病的作用:一个多中心的开放标签随机对照试验
Clinical nephrology
|April 12, 2024
概括
环胺与葡萄糖皮质类药物治疗相结合,显著改善了异常性膜性病的缓解率. 这种治疗还可以减少炎症和氧化应激,提供更有效的治疗选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 异形膜性病 (IMN) 是成年人性综合征的主要原因.
- 目前的治疗方法,主要是葡萄糖皮质激素,具有可变的疗效和潜在的副作用.
- 需要更有效的疗法来提高缓解率和管理IMN.
研究的目的:
- 评估循环胺与葡萄糖皮质类药物联合治疗IMN患者的疗效和影响.
- 为了比较这种联合治疗与葡萄糖皮质醇单一治疗的效果.
主要方法:
- 一个多中心,开放标签,随机对照试验与92名IMN患者进行.
- 患者被随机分配到对照组 (葡萄糖皮质激素) 和研究组 (cyclophosphamide + 葡萄糖皮质激素).
- 评估了包括功能,炎症标志物,免疫功能,氧化应激和脂质在内的关键指标.
主要成果:
- 组合治疗组的整体缓解率显著高 (93.48%vs. 78.26%).
- 在治疗后,研究小组表现出改善的功能,减少炎症标志物 (IL-6,IL-18,TGF-β,TNF-α) 和抑制氧化应激标志物.
- 组合疗法还导致免疫标记物 (抗PLA2R抗体,T淋巴细胞子集) 和脂质谱的有利变化.
结论:
- 环胺与葡萄糖皮质体治疗相结合是一种更有效的IMN治疗方法,而不是单独使用葡萄糖皮质体.
- 这种组合疗法在改善缓解率方面显示出显著的益处.
- 该疗法有效地抑制了关键的炎症和氧化应激通路,这些通路与IMN病原发生有关.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
161
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
161
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
136
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
136
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
240
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
240
Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242


